Pfizer and BioNTech start Biologics License Application for COVID-19 vaccine
Pfizer and BioNTech have started a rolling submission for a Biologics License Application (BLA) in the US for their COVID-19 vaccine.
Archives for May 7, 2021
Rapid detection of COVID-19 and its variants: Nicoya develops innovative saliva test kit
Ontario-based, Nicoya Lifesciences, is in the process of completing a prototype of a low-cost, single-use device that tests for active SARS-CoV-2 infection, variants and, eventually, other viruses. The novel test is called Atlas.
Sanofi and Stanford Medicine collaborate on immunology research
Sanofi and Stanford University School of Medicine have established a three-year research collaboration: focusing on autoimmune diseases and inflammatory conditions.
Will Biden backed bills boost biosimilars uptake in the US?
Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.